BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27468476)

  • 1. [Effect of "Gubentongluo Formula" on the IgA Class Switch Recombination of B Lymohocytes in Peyer's Patches in Mice with IgA Nephropathy].
    Shen PC; He LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):337-41. PubMed ID: 27468476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Gubentongluo Formula on Oxidative Stress Reflected by Expressions of PPARα and L-FABP in Mice with IgA Nephropathy].
    Li WW; Huang D; Shen PC; Wu Q; Sun C; Wang XX; He LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):210-215. PubMed ID: 28612528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.
    Zhong Q; Leung JC; Chan LY; Tsang AW; Chen X; Lai KN
    Am J Chin Med; 2005; 33(4):613-26. PubMed ID: 16173535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
    Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
    Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory effect of Astragalus membranaceus on the immune disorder in rats with IgA nephropathy].
    Peng XJ; Wu XC; Zhang GZ; Yi ZW; Zheng WM; He XJ; Mo SH; Tan H
    Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):55-60. PubMed ID: 18353241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immunoglobulin A production in Peyer's patches by oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (Shosaiko-to).
    Tauchi Y; Yamada A; Kawakita T; Saito Y; Suzuki A; Yoshikai Y; Nomoto K
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):251-72. PubMed ID: 8349952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-21 ensures TGF-beta 1-induced IgA isotype expression in mouse Peyer's patches.
    Seo GY; Youn J; Kim PH
    J Leukoc Biol; 2009 May; 85(5):744-50. PubMed ID: 19168593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21: a new player in the control of isotype switch in Peyer's patches.
    Pistoia V; Cocco C
    J Leukoc Biol; 2009 May; 85(5):739-43. PubMed ID: 19406834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
    Chen X; Peng S; Zeng H; Fu A; Zhu Q
    Indian J Pharmacol; 2015; 47(1):27-33. PubMed ID: 25821307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H; Ohtake H; Ishida A; Ohta N; Kakehata S; Yamakawa M
    J Clin Exp Hematop; 2012; 52(3):161-70. PubMed ID: 23269075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-beta-directed IgA switching and changes in B cell fate.
    Klein J; Ju W; Heyer J; Wittek B; Haneke T; Knaus P; Kucherlapati R; Böttinger EP; Nitschke L; Kneitz B
    J Immunol; 2006 Feb; 176(4):2389-96. PubMed ID: 16455997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy.
    Wu W; Jiang XY; Zhang QL; Mo Y; Sun LZ; Chen SM
    World J Pediatr; 2009 Aug; 5(3):211-5. PubMed ID: 19693466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression.
    Shi Y; Pestka JJ
    J Nutr Biochem; 2006 Oct; 17(10):697-706. PubMed ID: 16524712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.
    Shen P; Shen J; Sun C; Yang X; He L
    BMC Complement Altern Med; 2016 Aug; 16(1):312. PubMed ID: 27558012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro.
    Lin L; Shen J; Wu X; You Y; Li S
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.